Chordoma Characterization of Significant Changes of the DNA Methylation Pattern
Open Access
- 22 March 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3), e56609
- https://doi.org/10.1371/journal.pone.0056609
Abstract
Chordomas are rare mesenchymal tumors occurring exclusively in the midline from clivus to sacrum. Early tumor detection is extremely important as these tumors are resistant to chemotherapy and irradiation. Despite continuous research efforts surgical excision remains the main treatment option. Because of the often challenging anatomic location early detection is important to enable complete tumor resection and to reduce the high incidence of local recurrences. The aim of this study was to explore whether DNA methylation, a well known epigenetic marker, may play a role in chordoma development and if hypermethylation of specific CpG islands may serve as potential biomarkers correlated with SNP analyses in chordoma. The study was performed on tumor samples from ten chordoma patients. We found significant genomic instability by Affymetrix 6.0. It was interesting to see that all chordomas showed a loss of 3q26.32 (PIK 3CA) and 3q27.3 (BCL6) thus underlining the potential importance of the PI3K pathway in chordoma development. By using the AITCpG360 methylation assay we elucidated 20 genes which were hyper/hypomethylated compared to normal blood. The most promising candidates were nine hyper/hypomethylated genes C3, XIST, TACSTD2, FMR1, HIC1, RARB, DLEC1, KL, and RASSF1. In summary, we have shown that chordomas are characterized by a significant genomic instability and furthermore we demonstrated a characteristic DNA methylation pattern. These findings add new insights into chordoma development, diagnosis and potential new treatment options.This publication has 31 references indexed in Scilit:
- DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung CancerCancer Research, 2012
- Does insulin‐like growth factor 1 receptor (IGF‐1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical studyHistopathology, 2012
- EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylationBMC Cancer, 2011
- Recurrent Chromosomal Copy Number Alterations in Sporadic ChordomasPLOS ONE, 2011
- PCR-Based Analysis of Differentially Methylated Regions of GNAS Enables Convenient Diagnostic Testing of Pseudohypoparathyroidism Type IbClinical Chemistry, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Klotho, the long sought-after elixir and a novel tumor suppressor?Cancer Biology & Therapy, 2006
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- First cytogenetic study of a recurrent familial chordoma of the clivusInternational Journal of Cancer, 1999
- Chordoma: long-term follow-up after radical photon irradiationRadiotherapy and Oncology, 1996